Viewing Study NCT02530502


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-02-22 @ 7:50 AM
Study NCT ID: NCT02530502
Status: TERMINATED
Last Update Posted: 2023-11-18
First Post: 2015-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
Sponsor: Northwestern University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NU 15C01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None NIH View